ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017
Long-term outcomes of totally implantable venous access devices.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 28 citations in OpenAlex.
- Clinical Outcomes and Patient Satisfaction After Ultrasound- and Intracavitary ECG-Guided Totally Implantable Venous Access Port Implantation.Healthcare (Basel, Switzerland) · 2026Article
- Retrospective Analysis of Totally Implantable Venous Access Ports which was Performed using the Patient's Height as a Guide, and the Effect of Catheter Tip Position on Complications.Turkish journal of anaesthesiology and reanimation · 2026Article
- Predictors of Complications in Patients Undergoing Port Catheter Application: A Comparative Study.Asian Pacific journal of cancer prevention : APJCP · 2025Observational
- Predictive model for totally implanted venous access ports‑related long‑term complications in patients with lung cancer.Oncology letters · 2024Article
- Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.BMC cancer · 2024Article
- Clinical application of ultrasound-guided totally implantable venous access ports implantation via the posterior approach of the internal jugular vein.Journal of the Chinese Medical Association : JCMA · 2024Article
- Migration of silicone catheter into pleural space: a case report.Oxford medical case reports · 2023Article
- Risk Factors of Catheter-Related Infection in Unplanned Extubation of Totally Implantable Venous-Accessportsin Tumor Patients.Emergency medicine international · 2022Article
- Comparative structural analysis of polyurethane and silicone catheters of totally implantable venous access devices by micro-computed tomography.SAGE open medicine · 2021Article
- Fracture and embolization of an implantable venous access device in patient with atrial septal defect.Journal of surgical case reports · 2020Article
- Late complications associated with totally implantable venous access port implantation via the internal jugular vein.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020Article
- Comparison between ultrasound-guided TIVAD via the right innominate vein and the right internal jugular vein approach.BMC surgery · 2019Article
- Ultrasound-guided totally implantable venous access ports via the right innominate vein: a new approach for patients with breast cancer.World journal of surgical oncology · 2019Article
- Observational
- Experience in totally implantable venous port catheter: Analysis of 3,000 patients in 12 years.Turk gogus kalp damar cerrahisi dergisi · 2018Article
- Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders.Molecular genetics and metabolism reports · 2018Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeIdentifying risk factors for premature totally implantable venous access device (TIVAD) catheter removal is crucial; however, because of the diversity of study methodologies, there is no consensus on such factors. The objective of the present study was to identify such risk factors by applying a cohort design study with a long-term follow-up period.
methodsFor this cohort study, we selected cancer patients who had newly implanted TIVADs between July 2008 and December 2008. The follow-up period lasted until September 2012. Univariate analysis was performed for age, gender, cancer type, TIVAD brand, puncture site, sidedness of puncture, and catheter tip position. The hazard ratio (HR) of potential risk factors was calculated using the Cox proportional hazards regression model, and Kaplan-Meier curves were applied for catheter survival analysis.
resultsOur study consisted of 240 people, with 5 people lost to follow-up. The cumulative premature catheter removal rate of all TIVADs was 9.8%, with the most common reason for premature removal being port-associated blood stream infection (PABSI), which proved to be highest in patients with hematology cancer (27.8%) and upper gastrointestinal cancer (19.4%). Suboptimal tip position (HR 5.13, 95% confidence interval 1.73-15.21) was also a risk factor for premature removal, and it was correlated with symptomatic TIVAD occlusion (p = 0.0004).
conclusionsPABSI was the most common reason for premature catheter removal, with a varied incidence rate between different cancer types. Suboptimal tip position was also a risk factor. Confirming the final tip position after implantation is crucial. Infection control is important for TIVAD care, especially in high-risk cancer patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.